- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Carnegie Fund II - Biotechnology Sub-Fund
+ Add to WatchlistCARBIOA:LX
16.74 EURAs of 00:00:00 ET on 04/30/2013.
Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)
| Year To Date: | +25.02% | 3-Month: | +17.80% | 3-Year: | +24.02% | 52-Week Range: | 13.02 - 16.74 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +3.85% | 1-Year: | +34.89% | 5-Year: | +16.19% | Beta vs CXBT: | - |
Fund Profile & Information for CARBIOA
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
| Inception Date: | 10-10-2000 | Telephone: | 352-40-40-30-1 |
|---|---|---|---|
| Managers: | ULF ARVIDSSON | ||
| Web Site: | www.carnegieam.com | ||
Fundamentals for CARBIOA
| NAV | (on 2013-04-30) 16.74 |
|---|---|
| Assets (M) | (on 2013-04-30) 21.92 |
| Fund Leveraged | N |
| Minimum Investment | 15,000.00 |
| Minimum Subsequent Investment | - |
Dividends for CARBIOA
No dividends reported
Fees & Expenses for CARBIOA
| Front Load | - |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.10 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.10 |
Top Fund Holdings for CARBIOA
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 50,000 | 1,918,070 | 9.090% |
| Celgene Corp | 20,000 | 1,812,909 | 8.592% |
| Regeneron Pharmaceuticals Inc | 12,500 | 1,728,640 | 8.192% |
| Biogen Idec Inc | 11,000 | 1,629,077 | 7.720% |
| Alexion Pharmaceuticals Inc | 20,000 | 1,427,892 | 6.767% |
| Onyx Pharmaceuticals Inc | 19,286 | 1,352,636 | 6.410% |
| BioMarin Pharmaceutical Inc | 24,000 | 1,160,150 | 5.498% |
| Vertex Pharmaceuticals Inc | 24,000 | 1,044,153 | 4.948% |
| Seattle Genetics Inc | 33,000 | 922,240 | 4.371% |
| Salix Pharmaceuticals Ltd | 20,000 | 795,447 | 3.770% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page